We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$49.3M +$194K +3,286 +0.4%
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$31.5M
BlackRock
3
BlackRock
New York
$24.3M +$1.75M +29,540 +7%
ABG
4
Ally Bridge Group
New York
$18.7M +$1.78M +30,000 +10%
FP
5
Flagship Pioneering
Massachusetts
$16M
Vanguard Group
6
Vanguard Group
Pennsylvania
$15.1M +$255K +4,316 +2%
OFM
7
Omega Fund Management
Massachusetts
$12.4M +$4.22M +71,233 +46%
SB
8
Samsara BioCapital
California
$10.6M
O
9
OrbiMed
New York
$10M
AG
10
Artal Group
Luxembourg
$9.27M +$4M +67,500 +66%
ACM
11
Altium Capital Management
New York
$5.87M +$5.62M +95,024 +750%
EC
12
EcoR1 Capital
California
$5.45M
State Street
13
State Street
Massachusetts
$5.45M +$1.21M +20,390 +26%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$5.27M +$790K +13,344 +16%
RCM
15
RA Capital Management
Massachusetts
$4.91M
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$4.64M +$5.04M +85,230 New
SCM
17
Sio Capital Management
New York
$4.36M +$4.74M +80,000 New
CS
18
Candriam SCA
Luxembourg
$3.18M +$3.46M +58,427 New
Millennium Management
19
Millennium Management
New York
$3.04M +$2.3M +38,892 +230%
Northern Trust
20
Northern Trust
Illinois
$3.02M +$204K +3,451 +7%
Goldman Sachs
21
Goldman Sachs
New York
$2.73M -$803K -13,570 -21%
Morgan Stanley
22
Morgan Stanley
New York
$2.2M +$173K +2,921 +8%
Charles Schwab
23
Charles Schwab
California
$2.14M +$169K +2,863 +8%
Acadian Asset Management
24
Acadian Asset Management
Massachusetts
$1.93M +$2.1M +35,445 New
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$1.68M -$252K -4,252 -12%